Logo image of PCT

PURECYCLE TECHNOLOGIES INC (PCT) Stock Fundamental Analysis

USA - NASDAQ:PCT - US74623V1035 - Common Stock

14.345 USD
+0.43 (+3.05%)
Last: 9/23/2025, 1:10:49 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PCT. PCT was compared to 83 industry peers in the Chemicals industry. Both the profitability and financial health of PCT have multiple concerns. PCT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

PCT had negative earnings in the past year.
PCT had a negative operating cash flow in the past year.
In the past 5 years PCT always reported negative net income.
PCT had a negative operating cash flow in each of the past 5 years.
PCT Yearly Net Income VS EBIT VS OCF VS FCFPCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -100M -200M -300M

1.2 Ratios

PCT has a Return On Assets of -27.89%. This is amonst the worse of the industry: PCT underperforms 89.16% of its industry peers.
Looking at the Return On Equity, with a value of -73.99%, PCT is doing worse than 84.34% of the companies in the same industry.
Industry RankSector Rank
ROA -27.89%
ROE -73.99%
ROIC N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
PCT Yearly ROA, ROE, ROICPCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCT Yearly Profit, Operating, Gross MarginsPCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

3

2. Health

2.1 Basic Checks

The number of shares outstanding for PCT has been increased compared to 1 year ago.
PCT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PCT has an improved debt to assets ratio.
PCT Yearly Shares OutstandingPCT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
PCT Yearly Total Debt VS Total AssetsPCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

PCT has an Altman-Z score of 1.01. This is a bad value and indicates that PCT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.01, PCT is not doing good in the industry: 79.52% of the companies in the same industry are doing better.
PCT has a Debt/Equity ratio of 0.89. This is a neutral value indicating PCT is somewhat dependend on debt financing.
PCT has a worse Debt to Equity ratio (0.89) than 60.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.01
ROIC/WACCN/A
WACCN/A
PCT Yearly LT Debt VS Equity VS FCFPCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 2.14 indicates that PCT has no problem at all paying its short term obligations.
PCT has a Current ratio (2.14) which is comparable to the rest of the industry.
A Quick Ratio of 2.07 indicates that PCT has no problem at all paying its short term obligations.
PCT has a better Quick ratio (2.07) than 79.52% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 2.07
PCT Yearly Current Assets VS Current LiabilitesPCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

PCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -112.05%.
EPS 1Y (TTM)-112.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 16.92% on average over the next years. This is quite good.
PCT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 194.94% yearly.
EPS Next Y55.8%
EPS Next 2Y26.77%
EPS Next 3Y19.03%
EPS Next 5Y16.92%
Revenue Next Year817.91%
Revenue Next 2Y513.84%
Revenue Next 3Y496.19%
Revenue Next 5Y194.94%

3.3 Evolution

PCT Yearly Revenue VS EstimatesPCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 500M 1B 1.5B 2B
PCT Yearly EPS VS EstimatesPCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1

0

4. Valuation

4.1 Price/Earnings Ratio

PCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PCT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCT Price Earnings VS Forward Price EarningsPCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCT Per share dataPCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as PCT's earnings are expected to grow with 19.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.77%
EPS Next 3Y19.03%

0

5. Dividend

5.1 Amount

PCT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PURECYCLE TECHNOLOGIES INC

NASDAQ:PCT (9/23/2025, 1:10:49 PM)

14.345

+0.43 (+3.05%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners72.68%
Inst Owner Change0.08%
Ins Owners2.84%
Ins Owner Change0.83%
Market Cap2.58B
Analysts75.56
Price Target16.52 (15.16%)
Short Float %20.26%
Short Ratio11.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.02%
Min EPS beat(2)-285.57%
Max EPS beat(2)121.52%
EPS beat(4)1
Avg EPS beat(4)-99.62%
Min EPS beat(4)-285.57%
Max EPS beat(4)121.52%
EPS beat(8)3
Avg EPS beat(8)-59.39%
EPS beat(12)4
Avg EPS beat(12)-58.93%
EPS beat(16)5
Avg EPS beat(16)-46.25%
Revenue beat(2)0
Avg Revenue beat(2)-58.31%
Min Revenue beat(2)-60.11%
Max Revenue beat(2)-56.51%
Revenue beat(4)0
Avg Revenue beat(4)-79.15%
Min Revenue beat(4)-100%
Max Revenue beat(4)-56.51%
Revenue beat(8)0
Avg Revenue beat(8)-89.58%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.71%
PT rev (3m)24.62%
EPS NQ rev (1m)-41.57%
EPS NQ rev (3m)-47.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-35.61%
Revenue NQ rev (1m)-40.93%
Revenue NQ rev (3m)-38.42%
Revenue NY rev (1m)-15.28%
Revenue NY rev (3m)-19.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 799.81
P/FCF N/A
P/OCF N/A
P/B 6.57
P/tB 6.57
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS0.02
BVpS2.18
TBVpS2.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.89%
ROE -73.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.61%
ROA(5y)-13.78%
ROE(3y)-67.01%
ROE(5y)-44.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 184.6%
Cap/Sales 1686.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 2.07
Altman-Z 1.01
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3032.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-112.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.31%
EPS Next Y55.8%
EPS Next 2Y26.77%
EPS Next 3Y19.03%
EPS Next 5Y16.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year817.91%
Revenue Next 2Y513.84%
Revenue Next 3Y496.19%
Revenue Next 5Y194.94%
EBIT growth 1Y-27.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.11%
EBIT Next 3Y38.58%
EBIT Next 5Y32.73%
FCF growth 1Y45.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-98.85%
OCF growth 3YN/A
OCF growth 5YN/A